All-inclusive Westin Club Rooms group rate $320 per person per night double occupancy, $465 per night single occupancy, and $295 per person per night triple occupancy. Arrival Thursday (no earlier pre-dates available) Post dates are based on availability. All-Inclusive= room rate, all food and snacks, all drinks alcoholic or non-alcoholic, entertainment, taxes and gratuities. Certain sports activities may be extra.

https://www.marriott.com/en-us/hotels/lirwi-the-westin-reserva-conchal-an-all-inclusive-golf-resort-and-spa

Dr. Megan Willson, Pharm D.

Washington State University

Megan Willson is a Clinical Assistant Professor in the Pharmacotherapy Department of Washington State University College of Pharmacy.  Megan enjoys lecturing on cardiovascular topics as well as patient simulation scenarios in patient care laboratories. She also serves as preceptor to acute care fourth year pharmacy students in the area of internal medicine.

Friday April 16, 2027

DERMATOLOGICAL DISORDERS

ACPE# TBA

Objectives:

1.  Explain the pathophysiology of common skin conditions including immunologic and drug induced conditions.

2.  Perform patient assessments including focused history and physical examination to differentiate between and assess severity of drug reactions, acne, psoriasis, atopic dermatitis, and cellulitis.

3.  Recommend and compare therapy recommendations for each of the above dermatological conditions.

4.  Discuss adverse effects, safety, and use of biologic agents for the treatment of psoriasis.

---

Saturday April 17, 2027

HYPERTENSION & DYSLIPIDEMIA

ACPE# TBA

Objectives:

1.  Discuss hypertension based on equations and apply how medications reduce blood pressure.

2.  List primary and secondary forms of hypertension.

3.  Determine blood pressure goals and appropriate drug therapy recommendations consistent with hypertension guidelines in patients.

4.  Define MOA of each drug class and explain how it relates to HR, SV, CO, and SVR.

5.  Recommend appropriate lifestyle modifications and medication regimens based on individual’s history, concomitant disease, physical exam, and current medications.

6.  Discuss adverse effects and counseling points for each medication class.

7.  Review the medications for the treatment of dyslipidemia including class, MOA, contraindications, benefits, clinical pearls, and adverse effect profiles.

8.  Identify risk factors for dyslipidemia including lifestyle and drug-induced.

9.  Assess and identify treatment strategies for myalgias associated with statin therapy.

10.  Differentiate between statin intensity.

11.  Based on ASCVD score, recommend appropriate statin intensity therapy.

12.  Develop a therapeutic plan for the treatment of dyslipidemia including statins, PCKS-9 inhibitors, and ezetimibe.

---

Sunday April 18, 2027

ASTHMA & COPD

ACPE# TBA

Objectives:

1.  Describe and compare the pathophysiology, diagnosis, and classification for asthma and COPD.

2.  Select an appropriate pharmacologic regimen for chronic stable COPD and for acute exacerbations of COPD.

3.  Select an appropriate pharmacologic regimen for stable asthma and for acute exacerbations of asthma.

4.  Identify the class, MOA, place in therapy, and potential side effects of therapies.

5.  Discuss vaccine therapy recommendations for patients with asthma and COPD.